HOUSTON— Womble Bond Dickinson attorney Joshua Davis led a discussion of virtual IP trials at the Licensing Executives Society (U.S.A. and Canada), Inc. (LES) 2020 Annual Meeting held on October 15-20.  

Entitled “Remote Patent Trials and Depositions in the COVID World,” Davis’s presentation chronicled a case in which Womble Bond Dickinson earned a major patent victory for Ferring Pharmaceuticals, Inc. in the first Zoom trial in the Southern District of New York during the pandemic.  The 8-day trial in July 2020 was fully remote, with witnesses and counsel appearing via Zoom.  The firm was recognized by Law360 as a “Legal Lion” for its significant win in this case. 

Womble Bond Dickinson is a longtime supporter of LES.  The firm was recognized as gold level sponsor of the LES Annual Meeting. Karthika Perumal, Ph.D. currently serves as a member of the LES 2019-2020 Distinguished Board of Directors and was the co-Chair of the 2020 Annual Meeting.  Jeffrey Whittle, Managing Partner of the firm’s Houston office, is the past LES President & Chair, US and Canada.  Mark D. Shelley, II, Ph.D. currently serves as Senior Vice President of Education for LES. 

For over 50 years, the Licensing Executives Society (U.S.A. and Canada), Inc. (LES) has been the leading association for intellectual property (IP), technology, and business development professionals. The LES community drives strategy, transactions, and deals involving intellectual property, business, and law, to fuel the evolving innovation economy. LES is a member society of the Licensing Executives Society International, Inc. (LESI), which has 32 sister societies representing 8,000 members in 90 countries.

Joshua P. Davis has significant experience litigating patent infringement and validity issues in U.S. district court cases and at the U.S. Court of Appeals for the Federal Circuit, as well as at the U.S. Patent and Trademark Office and the U.S. International Trade Commission. Many of his cases concern pharmaceutical products, biotechnology, or medical devices, as well as chemical processes and manufacturing, wireless communication technologies, personal computing, operating and networking systems, semiconductor layout and design, and hardware and software implementations. Davis has extensive experience in Abbreviated New Drug Application (ANDA) cases, and has represented clients in district courts across the country, including the District of Delaware, District of New Jersey, Eastern District of Texas, and Northern District of California.